Recently antibodies with a wide range of binding specificities have been isolated from large repertoires of antibody fragments displayed on filamentous phage, including those that are difficult to raise by immunization. We have used this approach to isolate an antibody fragment against chicken very low density lipoprotein (VLDL) receptor. It binds to the receptor with good affinity (K aff ؍ 2 ؋ 10 8 M
؊1) as measured by plasmon surface resonance, and competes for binding of natural ligands (vitellogenin, VLDL, and receptor-associated protein). The antibody also binds to other members of the low density lipoprotein (LDL) receptor family including rat LDL receptor and human and rat low density lipoprotein receptor-related protein (LRP/␣ 2 MR), and it competes for binding of receptor-associated protein to LRP/␣ 2 MR. Moreover, the antibody fragment inhibits infection of human fibroblasts deficient in LDL-R but expressing LRP/␣ 2 MR by human rhinovirus. Binding of the antibody is abolished upon reduction of the receptors and is strictly Ca 2؉ dependent. The phage antibody thus recognizes the ligand binding site(s) of several members of the LDL receptor family, in contrast to antibodies produced by hybridoma technology.The low density lipoprotein (LDL) 1 receptor of mammals is the prototype of a family of related proteins. Members of the LDL receptor family have several structural modules in common; (i) "binding repeats," complement-type domains consisting of ϳ40 residues displaying a triple disulfide bondstabilized negatively charged surface (head-to-tail combinations of these repeats are believed to specify ligand interaction); (ii) epidermal growth factor precursor-type repeats, also containing six cysteines each; (iii) modules of ϳ50 residues with a consensus tetrapeptide, Tyr-Trp-Thr-Asp (YWTD); and (iv), in the cytoplasmic region, signals for receptor internalization via coated pits, containing the consensus tetrapeptide Asn-Pro-Xaa-Tyr (NPXY).The LDL receptor family includes at least 4 proteins; the LDL receptor (LDL-R), the low density lipoprotein receptor related protein (also termed LRP/␣ 2 MR), gp330 (also termed megalin), and the very low density lipoprotein (VLDL) receptor. The LDL receptor (LDL-R) has a cluster of 7 binding repeats and binds to apolipoprotein B (apoB) and apolipoprotein E (apoE) (1, 2). LRP/␣ 2 MR is a giant receptor (4525 amino acids) containing 4 clusters of 2 to 11 binding repeats and has many ligands including apoE (3), ␣ 2 M-proteinase complexes (4, 5) among others (4 -12), and a 39-kDa intracellular protein (receptor-associated protein or RAP). RAP binds to LRP/␣ 2 MR with high affinity, co-purifies with LRP/␣ 2 M from liver and placenta (13,14), and competes for binding with all known LRP/␣ 2 MR ligands (4, 7-9, 15, 16). Whereas the majority of the ligands bound by LRP/␣ 2 MR fail to be recognized by LDL-R, human rhinoviruses (HRVs) of the minor receptor group type attach to either of these proteins (8). Recently, it was shown that RAP also binds to LDL-R but with much lower ...